Piotr Nowaczyk

Dr. Piotr Nowaczyk

orcid

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 April 2011 in Cancer
Verified
Journal Article
Closed access
PDF file
KPKarol Polom
Karol Polom
DMDawid Murawa
Dawid Murawa
YRYoung‐Soo Rho
Young‐Soo Rho
PNPiotr Nowaczyk
Piotr Nowaczyk
MHMichael Hünerbein
Michael Hünerbein
PMPawel Murawa
Pawel Murawa

16 July 2012 in International Journal of Oncology
Verified
Journal Article
Open access
PDF file
NSNadia Saucedo-Zeni
Nadia Saucedo-Zeni
SMSteffi Mewes
Steffi Mewes
RNRobert Niestroj
Robert Niestroj
LGLukasz Gasiorowski
Lukasz Gasiorowski
DMDavid Murawa
David Murawa
KLKlaus Lücke
Klaus Lücke
The isolation of circulating tumor cells (CTCs) from the blood of patients afflicted with solid malignant tumors becomes increasingly important as it may serve as a ‘liquid biopsy’ with the potential of monitoring the course of the cancer disease and its response to cancer therapy, with subsequent molecular characterization. For this purpose, we functionalized a structured medical Seldinger guidewire (FSMW), normally used to obtain safe access to blood vessels and other organ cavities, with a chimeric monoclonal antibody directed to the cell surface expressed epithelial cell surface adhesion molecule (EpCAM). This medical device was optimized in vitro and its biocompatibility was tested according to the regulations for medical devices and found to be safe with no noteworthy side effects. Suitability, specificity and sensitivity of the FSMW to catch and enrich CTCs in vivo from circulating peripheral blood were tested in 24 breast cancer or non-small cell lung cancer (NSCLC) patients and in 29 healthy volunteers. For this, the FSMW was inserted through a standard venous cannula into the cubital veins of healthy volunteers or cancer patients for the duration of 30 min. After removal, CTCs were identified by immuno­cytochemical staining of EpCAM and/or cytokeratins and staining of their nuclei and counted. The FSMW successfully enriched EpCAM-positive CTCs from 22 of the 24 patients, with a median of 5.5 (0-50) CTCs in breast cancer (n=12) and 16 (2-515) CTCs in NSCLC (n=12). CTCs could be isolated across all tumor stages, including early stage cancer, in which distant metastases were not yet diagnosed, while no CTCs could be detected in healthy volunteers. In this observatory study, no adverse effects were noted. Evidently, the FSMW has the potential to become an important device to enrich CTCs in vivo for monitoring the course of the cancer disease and the efficacy of anticancer treatment.

1 February 2012 in European Journal of Surgical Oncology
Verified
Journal Article
Closed access
KPKarol Polom
Karol Polom
DMD. Murawa
D. Murawa
PNPiotr Nowaczyk
Piotr Nowaczyk
YRY.S. Rho
Y.S. Rho
PMP. Murawa
P. Murawa

1 January 2012 in Acta Chirurgica Belgica
Verified
Journal Article
Closed access
DMD Murawa
D Murawa
MHM Hünerbein
M Hünerbein
ASA Spychała
A Spychała
PNPiotr Nowaczyk
Piotr Nowaczyk
KPKarol Polom
Karol Polom
PMP Murawa
P Murawa
Background : A complication of esophageal surgery is leakage at the anastomosis site and one of the factors involved in this complication is poor blood flow in the distal portion of the tube. The aim of this study was to evaluate the feasibility of indocyanine green fluorescence imaging as a method of determining the perfusion of the gastric conduit after esophagectomy. Methods : We analysed 15 consecutive patients who underwent transhiatal esophagectomy (THE) due to cancer. All of the patients had reconstruction of the gastrointestinal tract using the gastric conduit. Before performing the anastomosis, the blood flow in the area of the tube was evaluated using intravenous indocyanine green and observing its vascular flow with a camera equipped with an infrared laser. Results : In all cases it was possible to visualize the vascular flow of indocyanine green within the region of the gastric tube. The fluorescence imaging system showed vascular insufficiency of the distal gastric conduit in 4 patients - in all of these patients the anastomosis was performed end-to-side and there was no subsequent leak. Leakage at the anastomosis site was observed in 1 patient (6,66%). The leak was observed in the 9th postoperative day, despite visualization of a good vascular supply of the tube. Conclusions : Indocyanine green fluorescence imaging of gastric tube allows for intraoperative modifications, but it must be noted that the patient’s comorbidities and general health may also increase the risk of anastomosis leakage.

13 March 2014 in Saudi Pharmaceutical Journal
Verified
Journal Article
Open access
Magdalena Waszyk-NowaczykMagdalena Waszyk-Nowaczyk
Magdalena Waszyk-Nowaczyk
PNPiotr Nowaczyk
Piotr Nowaczyk
MSMarek Simon
Marek Simon
Implementation of pharmaceutical care (PC) in Poland is of great importance to patients, who, on the one hand, often follow complex pharmacological treatment regimens recommended by several physicians of different specialties, and, on the other, take up the decision on self-treatment due to availability of OTC medications. The aim of the present study was to assess the opinion of both patients and physicians about implementation of PC service in Polish community pharmacies. A cross sectional study was carried out from September 2009 to September 2010 by a pharmacist (author of the study) on the basis of an anonymous questionnaire, where demand of physicians (n = 104) and patients (n = 202) for implementation of PC in a community pharmacy was assessed. The study was planned to determine the relationship between implementation of PC, cost and time of this service and patients’ and physicians’ socio-economic information. Responding patients (85.64%) and physicians (76.92%) unanimously confirmed the need for implementation of PC. Most people convinced of the service implementation were 88.89% of physicians under the age of 35 and all the respondents were over 65 years of age (p = 0.027), just as 93.33% with service lesser than 5 years and 73.68% of respondents working a maximum of 20 years (p = 0.023). Mainly according to 90.00% of physicians with specialty in internal medicine and 92.59% of physicians of the group “Others” (p = 0.012), PC should be implemented in pharmacies. Women more frequently than men reckoned that appointments with a pharmacist should last up to 15 min (p = 0.012). According to 77.78% of the youngest physicians and 83.33% of the oldest ones, appointments should last from 5 to 15 min (p = 0.049), and a similar opinion was shared by 80.77% of physicians without specialty and 77.78% of physicians of the group “Others” (p = 0.0009). According to patients, the mean cost of the visit should be USD 7. Physicians most often assessed the mean cost of the appointment at USD 14. This study provides new data about implementation of PC in Poland. The increased patients’ and physicians’ willingness to benefit from this service provides pharmacists with opportunities to develop PC in community pharmacies.

1 January 2011 in Reports of Practical Oncology and Radiotherapy
Verified
Journal Article
Closed access
KPKarol Polom
Karol Polom
DMDawid Murawa
Dawid Murawa
PNPiotr Nowaczyk
Piotr Nowaczyk
BABeata Adamczyk
Beata Adamczyk
EGElizabeth Giles
Elizabeth Giles
PMPaweł Murawa
Paweł Murawa
Treatment of breast fibroadenoma remains a subject of clinical discussion. Recommended methods include clinical observation or surgical excision of the lesion. The procedure involves hospitalisation and anaesthesia, leaving a scar on the breast. The aim of this study was to present the Centre's experience in removing lesions radiologically suspicious of fibroadenoma by means of an ultrasound-guided vacuum-assisted core-needle biopsy as an alternative to a classical surgery. Between March 2007 and April 2010, 196 ultrasound-guided vacuum-assisted biopsies were performed in the Mammotome Biopsy Laboratory of the 1st Surgical Oncology and General Surgery Department at the Greater Poland Cancer Centre in Poznań. The procedure was delivered to female patients aged 17-91 years (mean 40.8, median 39). Qualified for removal were ultrasound identified lesions described as fibroadenomas. The average size of excised lesions according to pre-biopsy ultrasound image was 13.53 ± 8.92 mm (median 11 mm, range 4-60 mm). In 184 cases (93.9%), benign lesions were found in the final histopathologic examination. Pre-cancer lesions were found in 10 cases, and invasive lesions in two cases. Overall, after follow-up ultrasound examination, four patients were qualified for subsequent surgical resection of lesions that had been left behind. Vacuum core-needle biopsy is an effective tool enabling removal of breast fibroadenomas. It combines features of a lesion resection and histopathologic material collection providing an access with minimum invasiveness.